KRAS G12C inhibitors and methods of using the same
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Amgen Inc.
A C C C C C A A A A A C C A C C C A A C C A C C A C
A61K C07D C07D C07D C07D C07D A61K A61K A61K A61K A61K C07D C07D A61P C07D C07D C07D A61K A61K C07D C07D A61K C07D C07D A61K C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Ryan Paul David John Nuria A. Longbin Nobuko Shon Youngsook Anthony B. John Gordon Thomas T. Jian Jennifer Rebecca Victor J. Brian Alan Patricia
Wurz Kopecky Tamayo Liu Nishimura Booker Shin Reed Allen Nguyen Chen Allen Cee Lanman Lopez